ClinicalTrials.Veeva

Menu

Effect of Intradialytic Exercises in Chronic Kidney Disease Patients

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Chronic Kidney Disease stage3

Treatments

Device: leg pedaling cycling device
Device: sand bags
Device: hemodialysis sessions

Study type

Interventional

Funder types

Other

Identifiers

NCT06293092
P.T.REC/012/004008

Details and patient eligibility

About

the purpose of this study is to compare between intradialytic aerobic versus resistive exercises on immunity response in patients with chronic kidney disease.

Full description

The patients of this study will randomly assigned into three equal groups (n=20)

  1. Study Group A (20 patients) will receive intradialytic aerobic exercise and medical treatment.
  2. Study Group B (20 patients) will receive intradialytic resistive exercise and medical treatment.
  3. Control Group C (20 patients) will receive medical treatment only (HD session and drugs) Each patient will receive the treatment program three times per week for three months.

Enrollment

60 patients

Sex

Male

Ages

50 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sixty men chronic kidney disease (grade III RF). They received regular hemodialysis sessions at least one year ago, each one for four hours, three times per week.
  • They had a history of type II Diabetes more than five years.
  • Their age will be ranged from 50-60 years old.
  • They are Fit for exercise by functional assessment using six minute walk test.
  • Their Hemoglobin level more than 10 g\dl.
  • Their Body Mass Index (BMI) will be ranged from "18.5" to "24.9".

Exclusion criteria

  • Severe cardiac disorders.
  • Severe orthopedic problems (for example fractures).
  • Hepatic encephalopathy.
  • Preexisting neuromuscular diseases (e.g. myasthenia gravis). •Severe chest diseases.
  • Spinal cord injuries involved the phrenic nerve.
  • Uncontrolled diabetes or hypertension
  • Patients receiving inefficient hemodialysis session.
  • Patients with other cause for inflammation e.g. malignancy and autoimmune disease.
  • Active bleeding as alveolar hemorrhage, hemoptysis.
  • Physical limitation that would limit cycling.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups

control group C
Experimental group
Description:
receive hemodialysis sessions
Treatment:
Device: hemodialysis sessions
study group A aerobic exercise
Experimental group
Description:
receive hemodialysis sessions and intradialytic aerobic exercise
Treatment:
Device: leg pedaling cycling device
Device: hemodialysis sessions
study group B resistive exercise
Experimental group
Description:
receive hemodialysis sessions and intradialytic resistive exercise
Treatment:
Device: hemodialysis sessions
Device: sand bags

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems